Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year

201348 citationsJournal Article

Authors

Ling Yeung · University of Hawaiʻi at Mānoa

Kyla Teramoto · University of Hawaiʻi at Mānoa

Abstract

Continuous monthly intravitreal ranibizumab decreases leakage and hemorrhage in eyes with exudative and hemorrhagic complications of PCV. Branching vascular networks persisted, and polypoidal complexes decreased in only 5/13 (38%) eyes with continuous antiangiogenic therapy at 1 year.

Topics & Keywords

Retinal Diseases and Treatments Retinal and Optic Conditions Glaucoma and retinal disorders

Publication Details

Published in: Ophthalmologica

Volume 231, Issue 2, pp. 94-102

DOI: 10.1159/000354072

Field-Weighted Citation Impact: 3.62

Command Palette

Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year

Authors

Abstract

Topics & Keywords

Publication Details